2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Lung Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gubish, CT; Hershberger, PA; Kanterewicz, B; Land, S; Nichols, M; Rothstein, ME; Shuai, Y; Siegfried, JM; Stabile, LP | 1 |
He, L; Hou, Y; Lv, M; Nie, Y; Wang, T; Zhao, G | 1 |
2 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Lung Neoplasms
Article | Year |
---|---|
Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Estrogen Receptor beta; Genistein; Ginsenosides; Humans; Ligands; Lung Neoplasms; Mitogen-Activated Protein Kinase 1; Nitriles; Protein Kinase Inhibitors; Sapogenins; Transcription Factors; Transcription, Genetic; Transfection | 2009 |
ERĪ²-mediated estradiol enhances epithelial mesenchymal transition of lung adenocarcinoma through increasing transcription of midkine.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Base Sequence; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Lung Neoplasms; Male; Middle Aged; Midkine; Nerve Growth Factors; Nitriles; Phenols; Propionates; Protein Binding; Pyrazoles; Response Elements; RNA Interference; Signal Transduction; Statistics, Nonparametric; Transcription, Genetic | 2012 |